Status:
COMPLETED
Xenogenic Collagen Matrix and Subepithelial Connective Tissue Graft in the Treatment of Gingival Recession
Lead Sponsor:
Damascus University
Conditions:
Gingival Recession Localized Moderate
Eligibility:
All Genders
18-47 years
Phase:
NA
Brief Summary
this study is a Clinical evaluation of using Xenogenic collagen matrix (XCM) plus coronally advanced flap (CAF) compared to subepithelial connective tissue graft (SCTG) plus coronally advanced flap to...
Detailed Description
The aim of this study is to clinically compare between the subepithelial connective tissue graft (SCTG) plus coronally advanced flap (CAF) which is defined as the golden standard for the treatment of ...
Eligibility Criteria
Inclusion
- Good general health.
- No contraindications for periodontal surgery.
- Presence of one localized gingival recession in each side of the maxilla and/or mandible, All recessions will be Class I defects (Miller 1985).
- The cemento-enamel junction (CEJ) is visible in the defective teeth.
- All patients demonstrating good plaque control.
- No previous periodontal surgery in the targeted area.
Exclusion
- Smokers.
- pregnant or nursing patients.
- history of malignancy, radiotherapy, or chemotherapy.
- Patients taking medications that affect mucosal healing.
- Patients with allergy to collagen.
- Previous participation in a clinical trial.
- Type-1 diabetes patients.
- Patient who have diseases that affect connective tissue metabolism.
Key Trial Info
Start Date :
August 25 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2020
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04082130
Start Date
August 25 2019
End Date
August 1 2020
Last Update
January 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Periodontics, University of Damascus Dental School
Damascus, Syrian Arab Republic, Syria, DM20AM18